![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 14/755 | |
A61K 38/37 | |||
A61K 38/48 | |||
C07K 19/00 |
(11) | Number of the document | 2417155 |
(13) | Kind of document | T |
(96) | European patent application number | 10715162.3 |
Date of filing the European patent application | 2010-04-06 | |
(97) | Date of publication of the European application | 2012-02-15 |
(45) | Date of publication and mention of the grant of the patent | 2013-06-19 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2010/054495 |
Date | 2010-04-06 |
(87) | Number | WO 2010/115866 |
Date | 2010-10-14 |
(30) | Number | Date | Country code |
212004 P | 2009-04-06 | US | |
186075 P | 2009-06-11 | US |
(72) |
STERGAARD, Henrik, DK
PUSATERI, Tony, US
BARNETT, Thomas R., US
BUCHARDT, Jens, DK
PESCHKE, Bernd, DK
KOFOD-HANSEN, Mikael, DK
ZUNDEL, Magali A., DK
BEHRENS, Carsten, DK
OLSEN, Eva H. Norling, DK
STENNICKE, Henning, DK
|
(73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
(54) | TARGETED DELIVERY OF FACTOR VIII PROTEINS TO PLATELETS |
TARGETED DELIVERY OF FACTOR VIII PROTEINS TO PLATELETS |